Bank of America
AURA icon

Bank of America’s Aura Biosciences AURA Stock Holding History

Bank of America’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$839K Sell
125,356
-39,829
-24% -$229K ﹤0.01% 4609
2025
Q4 		$900K Buy
165,185
+129,002
+357% +$766K ﹤0.01% 4591
2025
Q3 		$224K Buy
36,183
+10,550
+41% +$69K ﹤0.01% 6223
2025
Q2 		$160K Sell
25,633
-5,651
-18% -$33K ﹤0.01% 6283
2025
Q1 		$183K Sell
31,284
-20,002
-39% -$151K ﹤0.01% 6222
2024
Q4 		$422K Buy
51,286
+8,709
+20% +$82K ﹤0.01% 5676
2024
Q3 		$379K Buy
42,577
+5,582
+15% +$47.9K ﹤0.01% 5666
2024
Q2 		$280K Buy
36,995
+2,062
+6% +$15.1K ﹤0.01% 5708
2024
Q1 		$274K Sell
34,933
-527
-1% -$4.37K ﹤0.01% 5713
2023
Q4 		$314K Sell
35,460
-5,563
-14% -$47.1K ﹤0.01% 5809
2023
Q3 		$368K Sell
41,023
-2,782
-6% -$29.9K ﹤0.01% 5528
2023
Q2 		$541K Buy
43,805
+2,712
+7% +$29K ﹤0.01% 5235
2023
Q1 		$381K Buy
41,093
+13,878
+51% +$144K ﹤0.01% 5552
2022
Q4 		$286K Sell
27,215
-18,024
-40% -$229K ﹤0.01% 5726
2022
Q3 		$820K Buy
45,239
+9,896
+28% +$150K ﹤0.01% 5027
2022
Q2 		$501K Buy
35,343
+23,486
+198% +$389K ﹤0.01% 5425
2022
Q1 		$261K Buy
11,857
+4,131
+53% +$78.7K ﹤0.01% 6300
2021
Q4 		$131K Buy
+7,726
New +$138K ﹤0.01% 6738

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America's AURA Position: Q1 2026 in Review

Bank of America reduced its Aura Biosciences (AURA) stake by 24% in Q1 2026, selling an estimated $229K and leaving 125,356 shares worth $839K. The position accounts for ﹤0.01% of the portfolio, ranked #4609.

Bank of America first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $900K in Q4 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Bank of America held 125,356 shares of Aura Biosciences worth $839K as of Q1 2026.
  • Bank of America sold 39,829 Aura Biosciences shares in Q1 2026, an estimated $229K.
  • Aura Biosciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4609 holding.
  • Bank of America first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Bank of America's Aura Biosciences position peaked at $900K in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.